Molbio Diagnostics IPO
Price Band
₹768 – ₹807
Issue Size
₹939.7 Cr
Issue Dates
10 Aug – 12 Aug 2026
Listing Date
17 Aug 2026
About Molbio Diagnostics Limited
Global point-of-care (POC) molecular diagnostics company engaged in research, development, manufacturing and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. Developer of the proprietary 'Truenat' platform, a portable, battery-operated PCR-based molecular diagnostics system for resource-limited settings. Offers molecular testing solutions for over 30 diseases through 43 diagnostic assays including TB, COVID-19, HIV, Hepatitis B & C and HPV, and also provides radiology, digital pathology and breast health screening solutions through subsidiaries and strategic collaborations. Operates six manufacturing facilities across India and serves customers in over 90 countries.
IPO Details
| Price Band | ₹768 – ₹807 |
| Face Value | ₹1 |
| Issue Size | ₹939.7 Cr |
| Fresh Issue | ₹200 Cr |
| Offer for Sale | ₹739.7 Cr |
| Total Shares Offered | 1,16,46,246 |
| Listed On | Both |
Objects of the Issue
Funding capital expenditure towards setting up infrastructure for a research and development facility, Center of Excellence and connected office space (₹125.12 Cr); Funding capital expenditure towards purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit (₹80.81 Cr); and General Corporate Purposes. Total estimated: ₹205.93 Cr.
Key Financial Metrics
EPS (Basic)
₹14.56
P/E Ratio
55.43x
ROE
15.59%
ROCE
17.55%
Financial Performance
| Particulars (₹ Cr) | FY2024 (Mar 31, 2024) | FY2025 (Mar 31, 2025) | FY2026 (Mar 31, 2026) |
|---|---|---|---|
| Revenue | — | — | — |
| EBITDA | 185.09 | 256.64 | 328.24 |
| PAT | 83.54 | 138.58 | 164.14 |
| Total Assets | 1,221.06 | 1,461.56 | 2,148.42 |
| Net Worth | 807.94 | 952.95 | 1,144.68 |
| Total Borrowings | 174.58 | 123.16 | 412.64 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Investment by Category
| Category | Lot Size | Min Investment | Max Investment |
|---|---|---|---|
| retail_min | 18 shares | ₹14,526 | — |
| retail_max | 234 shares | — | ₹1,88,838 |
| shni_min | 14 × 252 | ₹2,03,364 | — |
| shni_max | 1224 shares | — | ₹9,87,768 |
| bhni_min | 69 × 1242 | ₹10,02,294 | — |
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB | 50% | No |
| Retail | 35% | Yes |
| NII | 15% | No |
Registrar & Lead Managers
Frequently Asked Questions
5 questions about Molbio Diagnostics IPO IPO
Important Dates
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Molbio Diagnostics IPO